Clinical Trial

A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
VH4770359 (also known as GSK4770359) is an antiretroviral compound. This first-in-human study aims to evaluate the safety, tolerability, and pharmacokinetics (PK) of orally administered VH4770359 in healthy participants. The findings from this study will support the design of future clinical studies of VH4770359 in people living with HIV.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-14
Trial Details
NCT Number NCT07525544
Lead Sponsor ViiV Healthcare
Conditions HIV Infections
Enrollment 214 participants
Start Date 2026-05-14
Primary Completion 2027-05-05 (estimated)
Study Completion 2027-05-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-13